Abliva AB (publ)

Abliva AB (publ)verified

NEVPF

Price:

$0.028

Market Cap:

$715.67M

Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in...[Read more]

Industry

Biotechnology

IPO Date

2014-03-20

Stock Exchange

OTC

Ticker

NEVPF

The ROE as of November 2025 (TTM) for Abliva AB (publ) (NEVPF) is -99.30%

According to Abliva AB (publ)’s latest financial reports and current stock price. The company's current ROE is -99.30%. This represents a change of 188.29% compared to the average of -34.45% of the last 4 quarters.

Abliva AB (publ) (NEVPF) Historical ROE (quarterly & annually)

How has NEVPF ROE performed in the past?

The mean historical ROE of Abliva AB (publ) over the last ten years is -83.28%. The current -99.30% ROE has changed 19.24% with respect to the historical average. Over the past ten years (40 quarters), NEVPF's ROE was at its highest in in the December 2015 quarter at -4.83%. The ROE was at its lowest in in the March 2022 quarter at -111.94%.

Quarterly (TTM)
Annual

Average

-83.28%

Median

-62.01%

Minimum

-297.45%

Maximum

0%

Abliva AB (publ) (NEVPF) ROE by Quarter and Year

Discovering the peaks and valleys of Abliva AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 597.21%

Maximum Annual ROE = 0%

Minimum Annual Increase = -100.00%

Minimum Annual ROE = -297.45%

Quarterly (TTM)
Annual
YearROEChange
20240%-100.00%
2023-135.06%161.15%
2022-51.72%-82.61%
2021-297.45%597.21%
2020-42.66%-29.08%
2019-60.16%-14.66%
2018-70.49%6.39%
2017-66.25%46.62%
2016-45.19%-29.24%
2015-63.86%55.05%

Abliva AB (publ) (NEVPF) Average ROE

How has NEVPF ROE performed in the past?

The current ROE of Abliva AB (publ) (NEVPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-62.26%

5-year avg

-105.38%

10-year avg

-83.28%

Abliva AB (publ) (NEVPF) ROE vs. Peers

How is NEVPF’s ROE compared to its peers?

Abliva AB (publ)’s ROE is greater than Medivir AB (publ) (-37.65%), greater than Relief Therapeutics Holding AG (-49.18%), less than Oncopeptides AB (publ) (9.01%), greater than Small Pharma Inc. (-78.43%), less than Alpha Cognition Inc. (184.34%), less than IntelGenx Technologies Corp. (126.70%), greater than Herantis Pharma Oyj (-724.30%), less than ImmuPharma plc (3.82%), greater than Mindset Pharma Inc. (-316.17%), less than MedPeer,Inc. (15.36%),

Build a custom stock screener for Abliva AB (publ) (NEVPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abliva AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abliva AB (publ) (NEVPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abliva AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Abliva AB (publ)'s ROE?

How is the ROE calculated for Abliva AB (publ) (NEVPF)?

What is the highest ROE for Abliva AB (publ) (NEVPF)?

What is the 3-year average ROE for Abliva AB (publ) (NEVPF)?

What is the 5-year average ROE for Abliva AB (publ) (NEVPF)?

How does the current ROE for Abliva AB (publ) (NEVPF) compare to its historical average?